Bioceres Crop Solutions Q4 Sales $82.20M Up From $48.16M YoY
Bioceres Crop Solutions (AMEX:BIOX) reported $82.20 million in sales this quarter. This is a 70.68 percent increase over sales of $48.16 million the same period last year.
Earnings Scheduled For September 9, 2021
Companies Reporting Before The Bell
• Li-Cycle Holdings (NYSE:LICY) is likely to report earnings for its third quarter.
Bioceres’ Rizobacter, Marrone Bio Innovation Say Expand Strategic Alliance To Supply Novel Seed Treatment In Brazil; Terms Not Disclosed
Rizobacter -- a subsidiary of Bioceres Crop Solutions Corp. (NYSE:BIOX) and a global leader in sustainable solutions for agriculture -- and Marrone Bio (NASDAQ:MBII) (MBI) -- an international leader in sustainable
PlantArcBio Announces Collaboration Agreement With Bioceres Crop Solutions To Develop Improved Biomass & Drought Tolerant Alfalfa
PlantArcBio, a leading gene discovery biotech company, announced today a new collaboration agreement with Bioceres Crop Solutions Corp. ("Bioceres") (NASDAQ:BIOX), a fully-integrated global provider
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.